V8 Peptides — Engineered Performance
Research Library
BPC-157 and TB-500 Storage and Stability Compared
BPC-157Reconstitution & Handling

BPC-157 and TB-500 Storage and Stability Compared

V8 Peptides Research TeamUpdated

Compiled from peer-reviewed literature and manufacturer analytical data for laboratory research reference.

Quick answer

How should BPC-157 and TB-500 be stored, and are they equally stable? Both product pages state 2–8 °C, −20 °C for long-term and protection from heat, moisture and light. Chemically they differ: neither has oxidation-prone residues, BPC-157 carries an Asp-Asp pair and a free N-terminus, and TB-500 is N-acetylated and ends in glutamine. Equilibrate sealed vials before opening, freeze single-use aliquots, thaw once, and define shelf life by HPLC data, since no validated figure exists. For laboratory research use only.

BPC-157 and TB-500 are stored on the same shelf and described by the same storage line, yet they are chemically quite different molecules, and the differences explain which parts of "keep it cold and dry" matter most for each. One is a fifteen-residue, proline-rich peptide with a free N-terminus; the other is a seven-residue peptide whose N-terminus is acetylated. This article compares the two on stability grounds: what each sequence implies about degradation routes, how the supplied storage conditions map onto them, and how a laboratory can generate its own stability data instead of relying on folklore. It is written for people who handle BPC-157 and TB-500; both are for laboratory research use only. Step-by-step reconstitution is covered in the library’s blend reconstitution guide and the general method in how to reconstitute a lyophilized peptide.

What the product pages state

Both product pages give the same storage instruction: refrigerate at 2–8 °C, use −20 °C for long-term storage, and protect from heat, moisture and light. Both are supplied as lyophilized powder in a sealed clear glass research vial in a 10 mg size with a ≥98% HPLC purity specification. The TB-500 page gives the sequence as Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln (Ac-LKKTETQ) with molecular formula C38H68N10O14 and a mass of about 889 Da; the BPC-157 page gives the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, which corresponds to C62H98N16O22 and about 1419.5 g/mol. Neither page states a shelf life, and none is claimed here.

PropertyBPC-157TB-500
Residues157 (N-acetylated)
Average massAbout 1419.5 g/molAbout 889 g/mol
FormulaC62H98N16O22C38H68N10O14
N-terminusFree amine (Gly)Acetylated (blocked)
Charged side chainsLys; Glu; Asp, AspLys, Lys; Glu
Approximate net charge near pH 7About −2About 0
Residues prone to oxidation (Cys, Met, Trp, His, Tyr)NoneNone
Supplied storage line2–8 °C; −20 °C long-term; protect from heat, moisture, light2–8 °C; −20 °C long-term; protect from heat, moisture, light

Formula, mass and net charge in the table are calculated from the sequences, not taken from a measurement. Net charge is approximate because side-chain pKa values shift with the local environment.

Sequence-driven degradation routes

General reviews of peptide and protein stability (Manning et al., 2010; Wang, 1999) group chemical degradation into hydrolysis, deamidation and isomerization, oxidation, and racemization, with physical degradation (aggregation, adsorption) alongside. The sequences determine which routes apply.

Oxidation. Neither peptide contains cysteine, methionine, tryptophan, histidine or tyrosine, the residues that oxidize most readily. Oxidation is therefore a minor risk for both compared with methionine-rich peptides, which is one reason their storage lines can be simple.

Aspartyl chemistry. BPC-157 contains two adjacent Asp residues. Geiger and Clarke (1987) showed that aspartyl and asparaginyl residues can degrade through a cyclic succinimide intermediate that opens to isoaspartyl or racemized products, and that the rate depends strongly on the residue that follows, with glycine the most permissive. In BPC-157 the Asp-Asp pair is followed by Ala and then Gly, so the highest-risk neighbor arrangement is not present, but slow aspartyl isomerization in solution remains a plausible route over long storage and one that an HPLC method with adequate resolution can detect.

Glutamine. TB-500 ends in glutamine. Glutamine can deamidate to glutamic acid, and an N-terminal glutamine can cyclize to pyroglutamate, though that second route is not available here because the N-terminus is acetylated leucine and the glutamine is at the C-terminus. Deamidation of glutamine is generally slower than that of asparagine, so the risk is real but modest in water at neutral pH.

Proteolytic and microbial degradation. Peptides are substrates for contaminating proteases and for microbial growth in unpreserved solutions. The N-terminal acetyl group of TB-500 blocks aminopeptidase attack at that end; BPC-157 has a free N-terminus. Ho and colleagues (2012) reported metabolites of N-acetylated LKKTETQ in vitro and in equine samples, which shows that the peptide is processed biologically even though it is chemically simple. Cox and colleagues (2017) reported a stable BPC-157 metabolite and found the parent peptide stable in urine for at least four days.

Physical stability: moisture, freezing and adsorption

Lyophilization removes water by sublimation and leaves a solid with low molecular mobility; what is lyophilization describes the process. In the sealed vial the main physical enemy is moisture ingress from a poorly sealed stopper or from opening a cold vial in humid air, because absorbed water allows the degradation routes above to proceed in the solid. Equilibrating to room temperature before opening, closing promptly and returning the vial to cold storage address it.

Freezing a solution introduces separate stresses, which Bhatnagar and colleagues (2007) separate in their review: cold denaturation, ice-water interfaces, and cryoconcentration of solutes. Short unstructured peptides are much less sensitive than proteins, but repeated cycles still add variance, so single-use aliquots thawed once are the standard precaution. Adsorption to plastic is the quiet loss mechanism; Goebel-Stengel and colleagues (2011) showed that plasticware and glassware materially affect peptide recovery. The charge difference in the table matters here: a peptide with net negative charge and one with near-zero net charge can adsorb differently to the same surface, and the loss is proportionally greatest at low concentration. Low-binding tubes and dilution immediately before use are advisable for both.

A comparative storage plan

Because the two compounds share a storage line, the plan can be shared; the table notes where their chemistry suggests different emphasis.

StateBoth compoundsExtra attention
Sealed vial, near-term2–8 °C, dry, dark; record receipt date and appearance—
Sealed vial, long-term−20 °C in a sealed secondary container; equilibrate before openingMoisture control matters most; chemistry in the solid is slow
Reconstituted stockCold, tightly capped, few entries; limit time in solutionBPC-157: watch for slow aspartyl changes by HPLC. TB-500: protect against microbial growth and proteases
AliquotsSingle-use, low-binding tubes, thawed onceDilute working solutions lose more to surfaces
Working dilutionPrepare immediately before useVerify concentration if it is critical

Time in solution should be defined by data. A minimal stability study takes aliquots of the same stock, holds them at 2–8 °C, −20 °C and room temperature, and analyzes them by HPLC at set intervals against a freshly prepared reference, with an acceptance criterion agreed in advance such as peak area within a stated percentage of the reference and no new peaks above a stated threshold. The related guides how long reconstituted peptides last, storing research peptides and BPC-157 room-temperature stability cover the same question for general and single-compound cases.

Storing the two peptides together: stock, blends and shared boxes

Storing two peptides in one freezer box invites mix-ups more than chemistry. Label every tube with the compound, lot, concentration and date; keep a map of positions; and use different tube colors or rack positions for the two compounds. If the two are co-lyophilized in one vial, as in the Wolverine stack product, the product’s own storage line applies to the whole vial, and the individual components cannot be separated back out; see peptide blends and research stacks for the reasoning. If the two are reconstituted separately and combined later, the combined solution is a new preparation with its own stability question and should be logged as such.

Concentration arithmetic is the same for each: c (mg/mL) = m (mg) ÷ V (mL), and molar concentration is [m ÷ MW] ÷ V, using about 1419.5 g/mol for BPC-157 and about 889 g/mol for TB-500. Use the reconstitution calculator for the numbers, and file the lot documentation from the COA library where a certificate has been published.

Signs that a stock should be set aside

Set a stock aside and document it when the solution is cloudy, shows particles or strands, has developed a tint, smells of anything, or has been through more freeze–thaw cycles or time outside the cold chain than the plan allows. Document an unexpected HPLC trace, including a new peak, a shift in retention time or a drop in main-peak area relative to the reference. Do not attempt to rescue such a stock by filtering or re-freezing without data; the cost of a fresh vial is small compared with the cost of an uninterpretable experiment. Visual cues are explained in peptide vial appearance: what is normal and cloudy peptide vial after reconstitution.

Frequently asked questions

How should BPC-157 and TB-500 be stored?

The product pages for both state: refrigerate at 2–8 °C, −20 °C for long-term, and protect from heat, moisture and light. Equilibrate sealed vials to room temperature before opening.

Are the two peptides equally stable?

They share a storage line but differ chemically. Neither contains Cys, Met, Trp, His or Tyr, so oxidation is a minor route for both; BPC-157 has an Asp-Asp pair and a free N-terminus, while TB-500 is N-acetylated and ends in glutamine.

Is there a published shelf life for reconstituted BPC-157 or TB-500?

No validated shelf life for research-grade material reconstituted in bacteriostatic or sterile water has been published, and none is claimed here. Define an acceptance criterion and measure by HPLC.

Why is an N-acetyl group relevant to stability?

It blocks the N-terminus, which removes aminopeptidase attack at that end and the free amine. It does not protect the rest of the chain.

Can aspartic acid residues degrade in BPC-157?

Aspartyl residues can isomerize through a succinimide intermediate (Geiger and Clarke, 1987), with a rate that depends on the following residue. In BPC-157 the Asp-Asp pair is followed by Ala, not Gly, so the highest-risk arrangement is absent, but slow change is plausible.

How many freeze–thaw cycles should a stock tolerate?

Plan for one thaw per aliquot. Freezing concentrates solutes and creates ice interfaces, and repeated cycles add variance.

Why does adsorption matter for these peptides?

Peptides stick to plastic and glass, and the fractional loss is largest at low concentration. Low-binding consumables and dilution just before use reduce it.

Does it matter if the vial is clear glass?

Clear glass gives no light protection, so keep the vial in its box or wrap it in foil, as the storage line requires protection from light.

How can I measure stability in my own laboratory?

Hold aliquots of one stock at 2–8 °C, −20 °C and room temperature, analyze them by HPLC at set intervals against a fresh reference, and decide the acceptance criterion in advance.

Do I store a co-lyophilized blend differently?

The product’s own storage line applies to the whole vial. The components cannot be separated back out, and a separately combined solution is a new preparation with its own stability question.

Related reading: BPC-157 and TB-500 Testing: What a Certificate Must Show, Why BPC-157 and TB-500 Are Paired in Research, BPC-157 and TB-500: Reading Preclinical Parameters.

References

  1. Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. doi:10.1007/s11095-009-0045-6
  2. Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharm. 1999;185(2):129-188. doi:10.1016/S0378-5173(99)00152-0
  3. Geiger T, Clarke S. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. J Biol Chem. 1987;262(2):785-794. PMID: 3805008
  4. Bhatnagar BS, Bogner RH, Pikal MJ. Protein stability during freezing: separation of stresses and mechanisms of stabilization. Pharm Dev Technol. 2007;12(5):505-523. doi:10.1080/10837450701481157
  5. Goebel-Stengel M, Stengel A, Taché Y, Reeve JR Jr. The importance of using the optimal plasticware and glassware in studies involving peptides. Anal Biochem. 2011;414(1):38-46. doi:10.1016/j.ab.2011.02.009
  6. Ho EN, Kwok WH, Lau MY, et al. Doping control analysis of TB-500, a synthetic version of an active region of thymosin β4, in equine urine and plasma by liquid chromatography-mass spectrometry. J Chromatogr A. 2012;1265:57-69. doi:10.1016/j.chroma.2012.09.043
  7. Cox HD, Miller GD, Eichner D. Detection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23H by LC-MS/MS. Drug Test Anal. 2017;9(10):1490-1498. doi:10.1002/dta.2152

Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.